• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童癌症中的铂类化合物:毒性与临床处理。

Platinum compounds in children with cancer: toxicity and clinical management.

机构信息

Division of Pediatric Oncology, Catholic University of Rome, Rome, Italy.

出版信息

Anticancer Drugs. 2013 Nov;24(10):1007-19. doi: 10.1097/CAD.0b013e3283650bda.

DOI:10.1097/CAD.0b013e3283650bda
PMID:23962902
Abstract

Platinum compounds are widely used in the treatment of pediatric tumors such as neuroblastoma, germ-cell tumors, osteosarcoma, retinoblastoma, hepatoblastoma, brain tumors (low-grade gliomas and medulloblastoma/PNET), and relapsed and refractory lymphomas. The three major platinum compounds (cisplatin, carboplatin, and oxaliplatin) have a similar pharmacokinetics profile and mechanism of action, but the differences in their chemical structure are responsible for their different antitumor activity and toxicity. In this review, we have described the main characteristics of cisplatin, carboplatin, and oxaliplatin, focusing on their toxic effects and possible strategies to prevent them to improve the clinical outcomes in pediatric cancer patients. The underlying mechanism of each platinum-related toxicity is shown together with the clinical manifestations. Furthermore, possible preventive strategies are suggested to reduce the negative impact of platinum compounds on the quality of life of children with cancer. Cisplatin seems to be mostly ototoxic and nephrotoxic, carboplatin mainly produces myelosuppression, whereas oxaliplatin induces predominantly peripheral sensory neurotoxicity. In contrast, nausea and vomiting can be linked to all platinum compounds, although cisplatin exerts the strongest emetic effect. A correct knowledge of pharmacokinetics and toxicological profile of platinum compounds may aid physicians prevent their toxicity on auditory, nervous, renal, and bone marrow function, improving the quality of life of pediatric cancer patients.

摘要

铂类化合物广泛用于治疗儿科肿瘤,如神经母细胞瘤、生殖细胞肿瘤、骨肉瘤、视网膜母细胞瘤、肝母细胞瘤、脑肿瘤(低级别胶质瘤和髓母细胞瘤/原始神经外胚层肿瘤)以及复发性和难治性淋巴瘤。三种主要的铂类化合物(顺铂、卡铂和奥沙利铂)具有相似的药代动力学特征和作用机制,但它们化学结构的差异导致其抗肿瘤活性和毒性不同。在这篇综述中,我们描述了顺铂、卡铂和奥沙利铂的主要特征,重点介绍了它们的毒性作用和可能的预防策略,以改善儿科癌症患者的临床结局。每种铂类相关毒性的潜在机制与临床表现一起显示。此外,还提出了可能的预防策略,以减少铂类化合物对癌症儿童生活质量的负面影响。顺铂似乎主要引起耳毒性和肾毒性,卡铂主要引起骨髓抑制,而奥沙利铂则主要引起周围感觉神经毒性。相比之下,恶心和呕吐可能与所有铂类化合物有关,尽管顺铂的致吐作用最强。正确了解铂类化合物的药代动力学和毒理学特征可以帮助医生预防其对听觉、神经、肾脏和骨髓功能的毒性,从而提高儿科癌症患者的生活质量。

相似文献

1
Platinum compounds in children with cancer: toxicity and clinical management.儿童癌症中的铂类化合物:毒性与临床处理。
Anticancer Drugs. 2013 Nov;24(10):1007-19. doi: 10.1097/CAD.0b013e3283650bda.
2
Toxicity of platinum compounds.铂化合物的毒性。
Expert Opin Pharmacother. 2003 Jun;4(6):889-901. doi: 10.1517/14656566.4.6.889.
3
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的不同输注持续时间
Cochrane Database Syst Rev. 2016 Aug 8(8):CD010885. doi: 10.1002/14651858.CD010885.pub3.
4
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的不同输注持续时间
Cochrane Database Syst Rev. 2014 Jun 26(6):CD010885. doi: 10.1002/14651858.CD010885.pub2.
5
Clinical pharmacokinetics and administration of established platinum drugs.已上市铂类药物的临床药代动力学与给药方法
Drugs. 2000;59 Suppl 4:19-27. doi: 10.2165/00003495-200059004-00003.
6
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的不同输注持续时间
Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD010885. doi: 10.1002/14651858.CD010885.pub4.
7
Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity.癌症医学中的铂类复合物:与毒性和治疗活性相关的药代动力学和药效学
Cancer Surv. 1993;17:189-217.
8
[Platinum antitumor complexes].[铂类抗肿瘤复合物]
Recenti Prog Med. 2015 Dec;106(12):618-28. doi: 10.1701/2094.22652.
9
The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.紫杉醇与新型铂类化合物在晚期卵巢癌治疗中的联合应用。
Int J Gynecol Cancer. 2001;11 Suppl 1:21-30. doi: 10.1046/j.1525-1438.2001.11(suppl.1)sup1021.x.
10
Comparative adverse effect profiles of platinum drugs.铂类药物的比较不良反应概况。
Drug Saf. 1995 Oct;13(4):228-44. doi: 10.2165/00002018-199513040-00003.

引用本文的文献

1
Medulloblastoma in Adolescents and Young Adults (AYA): Bridging Pediatric Paradigms and Adult Oncology Practice.青少年和青年髓母细胞瘤(AYA):弥合儿科模式与成人肿瘤学实践之间的差距
J Clin Med. 2025 Jun 24;14(13):4472. doi: 10.3390/jcm14134472.
2
The Role of V-ATPase ATP6V0D1 Subunit in Chemoresistance and Ellipticine-Induced Cytoplasmic Vacuolation in Neuroblastoma Cells.V-ATP酶ATP6V0D1亚基在神经母细胞瘤细胞化疗耐药及椭圆玫瑰树碱诱导的细胞质空泡化中的作用
Mol Cell Oncol. 2025 Jun 17;12(1):2518774. doi: 10.1080/23723556.2025.2518774. eCollection 2025.
3
Assessment and Management of Chemotherapy-Induced Ototoxicity in Children.
儿童化疗所致耳毒性的评估与管理
J Audiol Otol. 2025 Apr;29(2):79-85. doi: 10.7874/jao.2025.00073. Epub 2025 Apr 18.
4
Bioelectrical Impedance Analysis of Body Composition in Male Childhood Brain Tumor Survivors.男性儿童脑肿瘤幸存者身体成分的生物电阻抗分析
Diseases. 2024 Nov 28;12(12):306. doi: 10.3390/diseases12120306.
5
Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies - a systematic review.血液系统恶性肿瘤患者中铂类药物所致耳毒性的患病率——一项系统评价
Contemp Oncol (Pozn). 2024;28(2):98-104. doi: 10.5114/wo.2024.141774. Epub 2024 Jul 26.
6
Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy.IRE1α-XBP1 信号通路促进了 GDF15 介导的化疗厌食和体重减轻。
J Exp Med. 2024 Jul 1;221(7). doi: 10.1084/jem.20231395. Epub 2024 May 2.
7
Progress in the study of reproductive toxicity of platinum-based antitumor drugs and their means of prevention.铂类抗肿瘤药物生殖毒性的研究进展及其预防手段
Front Pharmacol. 2024 Feb 13;15:1327502. doi: 10.3389/fphar.2024.1327502. eCollection 2024.
8
Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma.用于评估化疗联合视网膜母细胞瘤局部治疗的转化筛选平台。
Cancer Sci. 2023 Sep;114(9):3728-3739. doi: 10.1111/cas.15878. Epub 2023 Jun 20.
9
Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors.铂类化合物导致儿童早期及长期耳毒性:患病率及危险因素
Biomedicines. 2023 Jan 18;11(2):261. doi: 10.3390/biomedicines11020261.
10
Computational Analysis of the Behavior of BODIPY Decorated Monofunctional Platinum(II) Complexes in the Dark and under Light Irradiation.BODIPY 修饰的单功能铂(II)配合物在黑暗和光照下行为的计算分析。
J Phys Chem A. 2022 Oct 13;126(40):7159-7167. doi: 10.1021/acs.jpca.2c04544. Epub 2022 Oct 4.